Methodological approaches to the assessment of orphan medicinal products when making decisions about their inclusion in the program of medicinal maintenance: international experience and possible ways of its adaptation to the conditions of the health care system of the russian federation
Abstract
The article presents a first attempt of implementation of the methodology multicriteriale analysis of decision making in the organization of the system of drug provision in the Russia. In this paper, the reasons to update the activity aimed to implement the described methodology, as well as a dedicated area of drug supply, which multicriterial analysis of decision-making is most in demand - namely, for the organization of drug provision of patients with orphan diseases.
Keywords
орфанные (редкие) заболевания,
орфанные лекарственные средства,
МАПР ,
rare diseases,
orphan drugs,
MCDA ,
multi-criteria decision analysis,
medicine provision,
health technology assessment,
МАПР ,
мультикритериальный анализ принятия решений,
организация лекарственного обеспечения,
оценка технологии здравоохранения
About the Authors
N. G. Goloenko
Scientific Centre for Expert Evaluation of Medicinal Products
Russian Federation
Russian Federation
R. I. Yagudina
Scientific Centre for Expert Evaluation of Medicinal Products
Russian Federation
Russian Federation
V. G. Serpik
Scientific Centre for Expert Evaluation of Medicinal Products
Russian Federation
Russian Federation
A. Yu. Kulikov
Scientific Centre for Expert Evaluation of Medicinal Products
Russian Federation
Russian Federation
References
1. Materials and statistical data of the European organization for rare diseases [Internet]. 2015 [cited 18 Nov 2016]. Avaible at: http://www.eurordis.org/.
2. The report of the Committee on orphan drugs [Internet]. 2015. 2015 [cited 18 Nov 2016]. Avaible at: https://goo.gl/O5mdJw.
3. Soldatov AA, Avdeeva ZhI, Alpatova NA, Medunitsyn NV, Lysikova SL. Orphan drugs and the principles of their marketing authorization procedures and clinical use. Biopreparation (Biopharmaceuticals) 2015; (3): 4–16. (in Russian)
4. Khabriev RU, Yagudina RI, Pravdyuk NG. Evaluation of health care technologies. M.: Medical information Agency; 2013. (in Russian)
5. Yagudina RI, Koroleva NI, Zelenova EG. A Rare disease. Orphan drugs. Sovremennaya organizatia lekarstvennogo obespecheniya 2012; 1: 6–21. (in Russian)
6. Yagudina RI, Zelenova EG, Koroleva NI. Orphan diseases. Sovremennaya organizatia lekarstvennogo obespecheniya. 2012; 1: 7–15. (in Russian)
7. Federal law N323-FZ dated 21.11.2011 «On fundamentals of citizens’ health protection in the Russian Federation». (in Russian)
8. Sullivan T. Using MCDA (Multi-Criteria Decision Analysis) to prioritise publicly- funded health care. Dunedin: Universityof Otago; 2012.
9. Sussex J, Rollet P, Garau M, Schitt C et al. Multi-Criteria Decision Analysis to Value Orphan Medicines. OHE ResearchPaper; 2013.
10. Goetghebeur M, Wagner M, Khoury H et al. Combining multicriteria decision analysis, ethics and health technology assessment: applying the EVIDEM decisionmaking framework to growth hormone for Turner syndrome patients. Cost Effectiveness and ResourceAllocation 2010; 8: 4.
11. Devlin N, Sussex J. Incorporating Multiple criteria in HTA. 2011.
12. Tony ¹ et al. Bridging health technology assessment (HTA) with multicriteria decision analyses (MCDA): field testing of the EVIDEM framework for coverage decisions by a public payer in Canada. BMC HealthServicesResearch 2011; 11: 329.
13. Baltussen R, Niessen L. Priority setting of health interventions: the need for multi-criteria decision analysis. Cost Effectiveness and Resource Allocation 2006; 4: 14.
14. Multi-criteria analysis: a manual. Department for Communities and Local Government: London. 2009.
15. Baltussen R, Youngkong S, Paolucci S, Niessen L. Multi-criteria decision analysis to prioritize health interventions: Capitalizing on first experiences. Health Policy 2010; 262–264.
16. Collins T, Rosetti M, Nachtmann H, James R. The use of multi-attribute utility theory to determine the overall best-in-class performer in a benchmarking study. Oldham 2004.
17. Hayez Q, Smet Y, D-Sight J. A New Decision Support System to Address Multi- Criteria Problems. CoDE-SMG TechnicalReportSeries. ISSN 2030–6296
18. Thokala P. Multiple criteria decision analysis for health technology assessment. 2011.
Review
For citations:
Goloenko N.G., Yagudina R.I., Serpik V.G., Kulikov A.Yu. Methodological approaches to the assessment of orphan medicinal products when making decisions about their inclusion in the program of medicinal maintenance: international experience and possible ways of its adaptation to the conditions of the health care system of the russian federation. Safety and Risk of Pharmacotherapy. 2017;5(2):53-60. (In Russ.)
Views:
1057
Email this article 